HJ445A

Overview

HJ445A is an orally active myoferlin ( MYOF ) inhibitor with a K d value of 0.17 μM against human targets. HJ445A directly binds to the MYOF-C2D domain to stabilize the MYOF protein, thereby regulating vesicle trafficking, cell proliferation, colony formation, migration and apoptosis processes in cancer cells, and exhibits anti-tumor efficacy. HJ445A can be used in gastric cancer-related research.

Application

Products | Products > Disease Areas > Gastric Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Myosin | Products > Signaling Pathways > Ferlin Family | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-163084
• CAS No.: 3032441-59-8
• Molecular Formula: C24H27N7O2
• Molecular Weight: 445.52
• Purity: 98.02%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (5.61 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source